JUVAF (Juva Life) EV-to-EBIT: 0.00 (As of Aug. 10, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Juva Life EV-to-EBIT?

Juva Life JUVAF -90.00% EV-to-EBIT is 0.00 as of Aug. 10, 2026.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Juva Life's Enterprise Value is $0.00 Mil. Juva Life's EBIT for the trailing twelve months (TTM) ended in Mar. 2023 was $-4.80 Mil. Therefore, Juva Life's EV-to-EBIT for today is 0.00.

The historical rank and industry rank for Juva Life's EV-to-EBIT or its related term are showing as below:

JUVAF's EV-to-EBIT is not ranked *
in the Drug Manufacturers industry.
Industry Median: 15.66
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Juva Life's Enterprise Value for the quarter that ended in Mar. 2023 was $16.88 Mil. Juva Life's EBIT for the trailing twelve months (TTM) ended in Mar. 2023 was $-4.80 Mil. Juva Life's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2023 was -28.45%.

Juva Life  (OTCPK:JUVAF) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Juva Life's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2023 ) =EBIT / Enterprise Value (Q: Mar. 2023 )
=-4.802/16.88128605
=-28.45 %

Juva Life's Enterprise Value for the quarter that ended in Mar. 2023 was $16.88 Mil.
Juva Life's EBIT for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.80 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Juva Life EV-to-EBIT Related Terms

Juva Life EV-to-EBIT Historical Data

* Premium members only.

The historical data trend for Juva Life's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Juva Life EV-to-EBIT Chart

Juva Life Annual Data
Trend Dec19 Dec20
EV-to-EBIT
0.00 -8.29

Juva Life Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Mar22 Jun22 Sep22 Mar23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.83 -6.41 -4.85 -4.02 -3.52

JUVAF vs AVRW, UPC, EVOK: EV-to-EBIT Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Juva Life's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Juva Life EV-to-EBIT vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Juva Life's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Juva Life's EV-to-EBIT falls into.


Juva Life EV-to-EBIT Calculation

Juva Life's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.000/-4.802
=0.00

Juva Life's current Enterprise Value is $0.00 Mil.
Juva Life's EBIT for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.80 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EV-to-EBIT →
What does a EV-to-EBIT of 0.00 mean?
Juva Life (JUVAF) has a EV-to-EBIT of 0.00 as of Aug. 10, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Juva Life and its competitors.
Is Juva Life's EV-to-EBIT too high?
Juva Life's current EV-to-EBIT is 0.00.
How does Juva Life's EV-to-EBIT compare to AVRW and UPC?
Juva Life's EV-to-EBIT of 0.00 can be compared against companies in the Drug Manufacturers industry. The industry median EV-to-EBIT is 15.66. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Drug Manufacturers company?
The median EV-to-EBIT among Drug Manufacturers companies is 15.66, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Juva Life and its competitors. For the Drug Manufacturers industry, the median EV-to-EBIT is 15.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Juva Life's current EV-to-EBIT is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Juva Life stock overvalued right now?
Juva Life (JUVAF) has a current EV-to-EBIT of 0.00. The current EV-to-EBIT is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Juva Life (JUVAF), the current EV-to-EBIT is 0.00 as of Aug. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Juva Life Business Description

Address 885 West Georgia Street, Suite 1400, Vancouver, BC, CAN, V6C 3E8
Juva Life Inc is a life science company with both pharmaceutical research and development and consumer facing operations in cannabis production and distribution.